Intelligent Bio Solutions Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2026, which ended Jun 30, 2026 was Sales Of Goods Cartidges at $2.5 million, 59% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Jun 30, 2025
|
FY 2024
Jun 30, 2024
|
FY 2023
Jun 30, 2023
|
FY 2022
Jun 30, 2022
|
FY 2021
Jun 30, 2021
|
|---|---|---|---|---|---|---|
| Revenue |
4
|
3
|
3
|
1
|
0
|
2
|
| Sales Of Goods Cartidges |
2
+41.1%
share 59.0%
|
2
+13.7%
share 57.7%
|
2
+113.9%
share 49.8%
|
1
share 57.6%
|
—
|
—
|
| Sales Of Goods Readers |
1
+26.8%
share 21.4%
|
1
-24.2%
share 23.3%
|
1
+179.5%
share 30.2%
|
0
share 26.7%
|
—
|
—
|
| Other Sales Accessories |
1
+43.0%
share 19.6%
|
1
share 19.0%
|
—
|
—
|
—
|
—
|
| Other Sales |
—
|
—
|
1
+217.0%
share 20.0%
|
0
share 15.7%
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INBS (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1725430
- Former names
- GBS Inc. (until Oct 18, 2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (until Sep 19, 2019)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.